Embed Size (px)
Citation preview
Covered in this Report• In this report, Technavio covers the present scenario
and the growth prospects of the global hospital-acquired disease testing market for the period 2015-2019.
• Technavio's report, Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
• The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years.
• The report includes a discussion of the key vendors operating in this market.
Global Hospital-acquired Disease Testing Market
2015-2019
USA – CANADA – UK – CHINA – INDIA
Market Overview
• Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities.
• These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses.
• Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses.
• Technavio's analysts forecast the global hospital-
acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.
To know more aboutGlobal Hospital-acquired Disease Testing Market
2015-2019,please mail us at
USA – CANADA – UK – CHINA – INDIA
Key Vendors and Regions
• Abbott Laboratories
• Becton and Dickenson
• bioMerieux
• Roche Diagnostics
• Akers Biosciences
• Alere
• Beckman Coulter/Danaher
• Cantel Medical
View Our Report: Global Hospital-acquired Disease Testing Market 2015-2019
• Americas
• EMEA
• APAC
Vendors Regions
USA – CANADA – UK – CHINA – INDIA
Key Findings
• There is mounting pressure on hospitals and other healthcare entities to reduce the healthcare expenditure without compromising the quality of treatment and increase better patient outcomes.
• Hence, there is increasing focus toward early diagnosis and preventive medicine to reduce the length of stay in the hospital and reduce treatment costs.
• Hospital acquired disease testing offers reliable and efficient diagnosis because of the development of various high-sensitivity kits, shorter turnaround times, higher productivity and smooth operation of instruments.
• Most infectious diseases can be successfully treated if the disease is diagnosed in its early stages.
• Therefore, individuals are recommended to undergo all the main infectious diagnostics tests to ensure a correct diagnosis.
• Using hospital acquired disease testing, the exact location of the infection can be pinpointed, thereby helping in formulating a treatment strategy.
USA – CANADA – UK – CHINA – INDIA
Key Questions Answered in Our Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Have a question of your own about this report?
Ask our Analysts
USA – CANADA – UK – CHINA – INDIA
• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.
• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.
About Technavio
Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo
USA – CANADA – UK – CHINA – INDIA
View Our Report
Global Hospital-acquired Disease Testing Market 2015-2019
93 Pages | SKU: IRTNTR6608
For media enquiries,
please drop us a mail at
For more on the scope of the report, mail us at
Thank You!
Mail us at: [email protected] can visit us at:www.technavio.com
USA – CANADA – UK – CHINA – INDIA
![Hospital Acquired Infections, Sources, Route of …...hospital acquired infections worldwide is Enterococci [17]. Three to seven percent of hospital-acquired bacterial infections are](https://img.dokumen.tips/doc/110x75/5e8d2da3c3edfd174827a4ae/hospital-acquired-infections-sources-route-of-hospital-acquired-infections.jpg)
